Odyssey Therapeutics Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $1.5MTTM through 30 Jun 2026
Margins
| Current |
|---|
Balance Sheet Health
Current Ratio11.36x
Cash & Equivalents$82M
Dividend
No dividend
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.